Question 1

What is OLMESARTAN MEDOXOMIL used for?

Accepted Answer

OLMESARTAN MEDOXOMIL (brand name Olmesartan Medoxomil) is a Other indicated for 1 INDICATIONS & USAGE Olmesartan medoxomil tablets are indicated for the treatment of hypertension in adults and children six years of age and older, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, including.

Question 2

How does OLMESARTAN MEDOXOMIL work?

Accepted Answer

OLMESARTAN MEDOXOMIL works through the following mechanism: 12.1 Mechanism of Action Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin converting enzyme (ACE, kininase II). Angiotensin II is the principal pressor agent of the renin-angiotensin system, with effects that include vasoconstriction, stimulation of synthesis and release of aldosterone, cardiac stimulation and renal reabsorption of sodium. Olmesartan blocks the vasoconstrictor effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor in vascular smooth muscle. Its action is, therefore, independent of the pathways for angiotensin II synthesis. An AT2 receptor is found also in many tissues, but this receptor is not known to be associated with cardiovascular homeostasis. Olmesartan has more than a 12,500-fold greater affinity for the AT1 receptor than for the AT2 receptor. Blockade of the renin-angiotensin system with ACE inhibitors, which inhibit the biosynthesis of angiotensin II from angiotensin I, is a mechani.

Question 3

What are the most common side effects of OLMESARTAN MEDOXOMIL?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for OLMESARTAN MEDOXOMIL. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is OLMESARTAN MEDOXOMIL the same as Olmesartan Medoxomil?

Accepted Answer

Olmesartan Medoxomil is a brand name for OLMESARTAN MEDOXOMIL. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

OLMESARTAN MEDOXOMIL

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations